Five years ago last week, the first cannabis stock, Canopy Growth, began trading on the public markets and today CGC stock is worth $15 billion, a rise of 2,139% per share since its debut, according to the Financial Post.
Canopy Growth Corp., then known as Tweed Inc., listed on Toronto’s TSX Venture Exchange on April 4, 2014 via a reverse takeover of a capital pool company. Shares closed that first day at C$2.59 and have gained over 2,139% since then to C$58 Thursday morning. If you were lucky enough to sell at its high of $76.91 in October, your return would have been 2,869%
At the time of the stock’s debut, Canada had only recently licensed the first commercial growers to provide marijuana to the country’s expanding base of medical users. The Conservative federal government under then-Prime Minister Stephen Harper had no intention of legalizing recreational use and it was unclear what the sector would look like in one year, much less five.
But Canopy, under chief executive officer Bruce Linton, bet that investors would want a piece of the cannabis industry. Since then, it’s been a consistent trailblazer on the public markets. It was the first marijuana company to uplist to the Toronto Stock Exchange, the first to be added to Canada’s benchmark S&P/TSX Composite Index, the first to hit US$1 billion in market value and the first to list its shares on the New York Stock Exchange.
It was also the first pot company to secure a major investment from a partner outside the industry when it announced an initial $245 million investment from Constellation Brands Inc. in October 2017 followed by an additional $5 billion in August 2018.
Linton himself has been a beneficiary of the gains. His stake of 2.5 million shares is worth $145 million on paper, according to Bloomberg data.
Other pot companies that went public in 2014 have also thrived.
Cronos Group Inc., which recently closed a $2.4 billion investment from tobacco firm Altria Group Inc., has gained nearly 3,000% from its first trading day on Dec. 17, 2014 when it was known as PharmaCan Capital Corp. Aphria Inc. is up nearly 1,500% since its debut on Dec. 8, 2014 and Organigram Holdings Inc. has gained about 400% from its closing price of $1.97 on its first trading day of Aug. 25, 2014.